Boston Scientific Corporation (BSX) has a MoatMap StockRank of 35/100 based on Quality (64/100), Value (31/100), and Momentum (29/100) factor scores. The current signal is HOLD. Boston Scientific Corporation is a healthcare company (medical devices) that may be a quality business with a moat (IP, switching costs). However, it lacks a specific asymmetric macro inflection point that the fund is seeking, making it a 'fine' company rather than a high-conviction 'APPROVE' for this concentrated portfolio.